7Baggers
 Rapport Therapeutics Appoints Chief Financial Officer - Business Wire Business Wire Mon, 30 Oct 2023 07:00:00 GMT
 How pharma wants to break the efficacy ceiling in IBD - Pharmaceutical Technology Pharmaceutical Technology Mon, 18 Sep 2023 07:00:00 GMT
 Citi GPS: Global Supply Chains - Business Wire Business Wire Thu, 12 Jan 2023 08:00:00 GMT
 Citi Launches SEPA Instant Payments in Europe - Business Wire Business Wire Wed, 04 May 2022 07:00:00 GMT
 Dengue - A Drug Pipeline Analysis Report by Technavio - Business Wire Business Wire Tue, 11 Sep 2018 07:00:00 GMT
 Citi launches new UK Autocall Fund Structure - Business Wire Business Wire Thu, 12 Dec 2013 08:00:00 GMT

ABIVAX Société Anonyme
(NASDAQ:ABVX) 

ABVX stock logo

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in P...

Founded: 2013
IPO Price: $11.6 (Oct 20, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends